|
|
|
|
|
|
|
|
 Thursday's market movers including ValiRx |
|
Data: 13/06/2013 06:52 - Billi: bambaec - 70 Views - Kategorija: Diversi
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
Kummenti... |
|
Videos relatati... |
|
|
|
|
|
|
|
|
|
|
Maltija 
